Home » Stocks » LFMD

LifeMD, Inc. (LFMD)

Stock Price: $21.94 USD 1.43 (6.97%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
After-hours: $22.00 +0.06 (0.27%) Feb 26, 7:52 PM
Market Cap 703.23M
Revenue (ttm) 28.34M
Net Income (ttm) -30.61M
Shares Out 14.67M
EPS (ttm) -2.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $21.94
Previous Close $20.51
Change ($) 1.43
Change (%) 6.97%
Day's Open 20.72
Day's Range 19.62 - 29.40
Day's Volume 766,666
52-Week Range 5.81 - 33.02

News

GlobeNewsWire - 5 days ago

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc .  (NASDAQ: CVLB) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, will begin trading at the opening of the mark...

Other stocks mentioned: CVLB

About LFMD

Conversion Labs operates as a telemedicine company with a portfolio of online direct-to-consumer brands. The company combines virtual medical treatment with prescription medications and over-the-counter products. Its network of physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. Its brand portfolio comprises of brands targeting market segments, such as hair loss, immune health, men's health, and disaster preparedness. The company was formerly known as Immudyne, Inc. and changed its name to Conver... [Read more...]

Industry
Pharmaceutical Retailers
Founded
1994
CEO
Justin Schreiber
Employees
26
Stock Exchange
NASDAQ
Ticker Symbol
LFMD
Full Company Profile

Financial Performance

In 2019, LifeMD's revenue was $12.47 million, an increase of 49.79% compared to the previous year's $8.32 million. Losses were -$3.14 million, 152.8% more than in 2018.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for LifeMD stock is "Strong Buy" and the 12-month stock price forecast is 37.50.

Price Target
$37.50
Analyst Consensus: Strong Buy